SEONGNAM, South Korea–(BUSINESS WIRE)– #ADC–Qurient announced a Science Advances study showing its selective CDK7 inhibitor Q901 enhances the antitumor activity of TOP1i-ADCs.
Tag: Business Wire
LOS ANGELES–(BUSINESS WIRE)—- $AVXL–Anavex Life Sciences Corp. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – AVXL
LOS ANGELES–(BUSINESS WIRE)—- $AVXL–Anavex Life Sciences Corp. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – AVXL
CHARLESTON, W.Va.–(BUSINESS WIRE)–City Holding Company, “the Company” (NASDAQ: CHCO), a $6.8 billion bank holding company headquartered in Charleston, on September 30, 2026 declared a dividend of $1.00 per common share for shareholders of record as of October 15, 2026. The dividend is payable on October 30, 2026. The dividend represents a 15% increase from the 87 cents per share cash dividend paid in the second quarter of 2026. “City’s board today once again reaffirmed the Company’s commitmen
CHARLESTON, W.Va.–(BUSINESS WIRE)–City Holding Company, “the Company” (NASDAQ: CHCO), a $6.8 billion bank holding company headquartered in Charleston, on September 30, 2026 declared a dividend of $1.00 per common share for shareholders of record as of October 15, 2026. The dividend is payable on October 30, 2026. The dividend represents a 15% increase from the 87 cents per share cash dividend paid in the second quarter of 2026. “City’s board today once again reaffirmed the Company’s commitmen
DALLAS–(BUSINESS WIRE)– #AirCargo–Ameriflight appoints David Harvey as President & CEO, bringing 25+ years of aviation leadership to drive the company’s next phase of growth.
DALLAS–(BUSINESS WIRE)– #AirCargo–Ameriflight appoints David Harvey as President & CEO, bringing 25+ years of aviation leadership to drive the company’s next phase of growth.
ATLANTA–(BUSINESS WIRE)– #1031Exchanges–AdvizorPro now features private placement data for sponsors and issuers raising capital through private offerings, creating one correct, working view.
圣地亚哥–(BUSINESS WIRE)–(美国商业资讯)– Maravai LifeSciences（NASDAQ: MRVI）旗下的全球生命科学试剂与服务供应商TriLink BioTechnologies, LLC（TriLink®），今日宣布已获得中国国家知识产权局（CNIPA）授予的一项新专利（专利号：ZL202511246658.5），专利名称为“5′-加帽RNA的组合物及合成方法”。这是TriLink在短短数月内在中国获得的第二项CleanCap®专利，标志着其在该地区的知识产权保护范围得到进一步拓展。 这项新专利与此前公布的中国专利（专利号：ZL202511246578.X）相互补充且各有侧重——后者重点保护合成加帽RNA分子的方法，而本次新授权的专利则直接保护CleanCap®帽结构类似物化合物本身，以及包含这些化合物的RNA分子、含有此类RNA分子的细胞，和包含CleanCap®加帽RNA的药物组合物（含成品制剂）。这两项专利共同构建起多层次的知识产权壁垒，不仅涵盖了制备CleanCap®加帽RNA的工艺过程，更直接覆盖了该工艺核心的基础分子结构。 TriLi
ATLANTA–(BUSINESS WIRE)–Ahead of Sober October, a new survey from Reframe, the leading alcohol-reduction app in the U.S. with the largest user base, suggests that participants are looking for more than a month without alcohol. They are using the challenge to support their mental health, improve their overall well-being and take a closer look at their relationship with drinking. The September survey of 763 members of the Reframe community found that more than eight in 10 respondents (82%) cite